AGF Investments Inc’s Vir Biotechnology VIR Stock Holding History

AGF Investments Inc’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$268K	Buy	13,892 +3,068	+28%	+$78K	﹤0.01%	438
2022 Q2	$276K	Buy	+10,824	New	+$253K	﹤0.01%	399
2022 Q1	–	Sell	-10,846	Closed	-$454K	–	705
2021 Q4	$454K	Buy	10,846 +7,246	+201%	+$284K	﹤0.01%	485
2021 Q3	$157K	Sell	3,600 -474	-12%	-$20.5K	﹤0.01%	658
2021 Q2	$193K	Buy	4,074 +1,284	+46%	+$58.4K	﹤0.01%	573
2021 Q1	$143K	Sell	2,790 -4,130	-60%	-$223K	﹤0.01%	685
2020 Q4	$185K	Buy	+6,920	New	+$225K	﹤0.01%	644

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AGF Investments Inc's VIR Position: Q3 2022 in Review

AGF Investments Inc increased its Vir Biotechnology (VIR) stake by 28% in Q3 2022, buying an estimated $78K and bringing the position to 13,892 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #438.

AGF Investments Inc first reported a position in VIR in Q4 2020 and has held it in 7 quarters since. The position peaked at $454K in Q4 2021. 220 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

AGF Investments Inc held 13,892 shares of Vir Biotechnology worth $268K as of Q3 2022.
AGF Investments Inc bought 3,068 Vir Biotechnology shares in Q3 2022, an estimated $78K.
Vir Biotechnology made up ﹤0.01% of AGF Investments Inc's portfolio in Q3 2022, its #438 holding.
AGF Investments Inc first reported a position in Vir Biotechnology in Q4 2020 and has held it in 7 quarters since.
AGF Investments Inc's Vir Biotechnology position peaked at $454K in Q4 2021.
220 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on AGF Investments Inc's 13F filing for Q3 2022, filed 10 Nov 2022.